Clinical Trials Logo

Clinical Trial Summary

Peripartum cardiomyopathy (PPCM) is a global disease with significant morbidity and mortality of young women. Its' etiology, epidemiology and treatment is not yet well described. This will be a retrospective, national, multicenter observational study, conducted in Turkey. It is expected that approximately 50 women with PPCM will be recorded.


Clinical Trial Description

Peripartum cardiomyopathy (PPCM) is a global disease with significant morbidity and mortality of young women. Its' etiology, epidemiology and treatment is not yet well described. This will be a retrospective, national, multicenter observational study, conducted in centres in Turkey. It is expected that approximately 50 women with PPCM will be recorded.

The objectives of the study are:

To define the clinical status and clinical characteristics of PPCM in Turkey

To define the outcome of PPCM (short and long term)

To define the demographical and possible etiological factors

To define prognostic factors ;


Study Design


Related Conditions & MeSH terms


NCT number NCT03364140
Study type Observational
Source Ege University
Contact Meral Kayikcioglu, MD
Phone +902323905448
Email meral.kayikcioglu@gmail.com
Status Recruiting
Phase N/A
Start date July 2, 2017
Completion date January 15, 2018

See also
  Status Clinical Trial Phase
Completed NCT04144660 - "Treatment Use of ECMO In Pregnancy or Peripartum Patient."
Withdrawn NCT04143997 - Diastolic Dysfunction PPCM in Patients With Documented Left Ventricular Systolic Function Recovery
Completed NCT00998556 - Effect of Bromocriptine on Left Ventricular Function in Women With Peripartum Cardiomyopathy Phase 2
Completed NCT03081949 - Peripartum Cardiomyopathy in Nigeria Registry Phase 4
Completed NCT04049136 - NT-proBNP Levels and Obesity in Pregnancy
Recruiting NCT04234659 - PPCM Observational Study (Peripartum Cardiomyopathy)
Withdrawn NCT02590601 - Bromocriptine in the Treatment of Peripartum Cardiomyopathy Phase 3
Completed NCT03907267 - Taurine in Peripartum Cardiomyopathy Phase 2/Phase 3
Recruiting NCT05878041 - Creation of a Multicenter National Registry for Peripartum Cardiomyopathy.
Recruiting NCT04927715 - Irisin Expression and Gene Polymorphism With Peripartum Cardiomyopathy.